Monday, August 3, 2026
☀️ Somewhere right now, a sea turtle that hatched in 1962 is still just vibing in the Pacific—no mortgage, no market anxiety, just pure existence. Channel that energy today.
August 2, 2026 — 4:00 PM ET close (Friday)
Amazon surged 15.63% on Friday after crushing Q2 earnings expectations with AWS cloud revenue growth accelerating to 19% YoY, signaling sustained demand from AI infrastructure buildout. The e-commerce giant's operating margin expanded to 8.2%, the highest in five years, as cost discipline offset inflationary pressures. This rally reflects investor conviction that hyperscalers will continue capturing outsized value from the AI capex cycle, positioning Amazon as a primary beneficiary of enterprise spending on compute and storage infrastructure.
Oil prices tumbled Monday as US President Donald Trump signaled fresh talks with Iran would begin, holding off on a new attack. WTI crude fell 4.56% to $80.81, while Brent crude declined 5.89% to $79.68. The selloff reflects a sharp reduction in geopolitical risk premium—markets had been pricing in potential supply disruptions from Iran-related conflict, but the ceasefire talks suggest that risk is receding. Lower oil prices reduce inflation expectations, which supports the Fed's pause on rate hikes and could even increase the odds of cuts later this year. However, Iran denied that negotiations with Washington were underway, introducing uncertainty into the narrative. The oil market remains sensitive to any escalation headlines.
Gold prices fell 1.29% to $4,107 per ounce on Monday as investors balanced support from a weaker US dollar against reduced safe-haven demand amid easing geopolitical tensions. The decline is consistent with a broader risk-on rotation: as oil prices fell and Iran ceasefire talks progressed, the urgency to hold non-yielding gold diminished. Additionally, the real yield (10Y Treasury yield of 4.68% minus inflation expectations of ~2.5%) is rising, making gold less attractive relative to rate-sensitive growth stocks. Gold remains 19.7% higher YTD, but the momentum has shifted from defensive to cyclical.
The US Dollar Index (DXY) fell 0.08% to 99.91 on Monday as geopolitical tensions eased and investors rotated into risk assets. A weaker dollar is typically bullish for emerging markets and commodities, as it makes US exports cheaper and foreign earnings more valuable when converted back to dollars. The DXY remains down 1.2% YTD, reflecting a structural shift toward lower real yields in the US relative to other developed markets. However, the dollar's weakness is modest, suggesting that safe-haven demand remains present despite the risk-on sentiment.
Japan's Nikkei 225 Index jumped 4.03% to 64,362 on Friday, extending gains from the previous session and tracking Wall Street higher amid a global rally in semiconductor stocks and renewed optimism surrounding the AI sector. Investor sentiment was lifted by strong earnings from Microsoft and Amazon, whose shares surged after reinforcing confidence in hyperscaler investment and sustained AI-driven demand. In Japan, Advantest soared another 15.7% after raising its annual operating profit forecast by 35%, fueled by robust demand for AI-related chip-testing equipment. Other major technology gainers included Tokyo Electron (+6.2%), Kioxia Holdings (+2.9%), SoftBank Group (+14.2%), Fujikura (+12%), and Lasertec (+13.7%). The Bank of Japan left its policy rate unchanged at 1%, in line with expectations. The Nikkei's strength reflects a global rotation into AI-exposed equities, with Japanese semiconductor equipment makers benefiting from the capex cycle.
The Institute for Supply Management's Manufacturing PMI posted a 55.6 reading on Monday, up 2.3 points from June and the best since May 2022, according to data released this morning. Economists surveyed by Dow Jones had expected 54.0. The survey gauges the percentage of companies reporting growth, so anything above 50 indicates expansion. New export orders and backlog orders both rose 4.5 points to respective readings of 53.0 and 55.0, while production jumped to 58.5, up 6.3 points. Employment climbed to 52.8, up 3.1 points to its highest since August 2022 and in expansion for the first time in 33 months. The prices index stayed solidly in growth territory at 71.1, down 1.9 points from June. This data suggests the US economy is accelerating into the second half of 2026 despite geopolitical headwinds and elevated interest rates. The manufacturing rebound is particularly significant because it signals that the Fed's pause on rate cuts is working—companies are investing in capacity and hiring again without needing monetary stimulus. The employment expansion is the real story: after months of labor market softness, manufacturers are now confident enough to add headcount, which could ease recession fears and support consumer spending. However, the elevated prices index (71.1) shows that input cost pressures remain, keeping inflation expectations sticky and likely keeping the Fed on hold through at least September.
💡 ISM Manufacturing PMI (Purchasing Managers' Index) — a monthly survey of manufacturing executives that measures business conditions on a scale of 0–100. Readings above 50 indicate expansion, below 50 indicate contraction. It's a leading indicator of economic health because manufacturers typically adjust production and hiring before broader economic shifts occur.
Microsoft and Alphabet both posted strong earnings Friday, with Alphabet's 6.9% gain outpacing Microsoft's 3.0% rise as investors digested better-than-expected cloud revenue and AI service adoption. Alphabet's cloud division posted double-digit growth, while Microsoft's Azure saw accelerating demand from enterprise customers building AI applications. The earnings beat signals that the hyperscaler capex cycle—where companies like Amazon, Microsoft, and Alphabet spend tens of billions on data centers and GPUs to support AI workloads—is still in early innings. This concentration of AI spending among the 'Magnificent Seven' is creating a structural advantage: these companies have the balance sheets to fund massive capex, the customer relationships to monetize AI services, and the scale to drive down unit economics. Smaller cloud providers and chip companies are being squeezed as enterprises consolidate spending with the largest players.
💡 Hyperscaler capex cycle — the period when large cloud providers (Amazon, Microsoft, Google, Meta) invest heavily in data center infrastructure and GPUs to support AI model training and inference. This cycle typically lasts 3–5 years and drives earnings growth for the companies and their suppliers (chip makers, networking equipment vendors).
SpaceX's Launch Services revenue declined 42% year-over-year in Q1 2026 to $330M, down from $566M in the prior-year quarter, according to analyst notes released Monday. The decline reflects delays in scheduled launches, which have pushed revenue recognition into later quarters. Starlink and Starship progress remain critical for the company's long-term strategy, as Starship is essential for deploying next-generation Starlink satellites and supporting the company's broader AI and connectivity ambitions. The revenue miss is a reminder that even dominant aerospace companies face execution risk, and delays in launch cadence can ripple through the supply chain and delay customer deployments. However, analysts remain constructive on the long-term opportunity, as Starship's reusability economics could transform the space industry.
AstraZeneca and Bristol Myers Squibb are in advanced merger talks, according to sources familiar with the matter, with discussions focused on an all-stock or mixed consideration structure. Bristol Myers Squibb is up 4% in premarket trading Monday, while AstraZeneca ADRs are down 5.8%, reflecting uncertainty over deal terms. A combined entity would create a $300B+ pharmaceutical powerhouse with leading positions in oncology, immunology, and cardiovascular disease. The deal would allow the combined company to eliminate duplicate R&D programs, consolidate manufacturing footprints, and accelerate time-to-market for late-stage assets. Pharma consolidation has accelerated in 2026 as companies seek to offset patent cliffs and rising drug development costs. However, regulatory scrutiny remains a wildcard—antitrust authorities may challenge the deal if they view it as reducing competition in key therapeutic areas.
💡 Patent cliff — the period when a blockbuster drug's patent expires, allowing generic competitors to enter the market and eroding the company's revenue. Pharma companies consolidate to offset patent cliffs by acquiring companies with newer drugs in their pipeline.
MicroStrategy disclosed Monday that it sold 1,638 BTC for $104.7M between July 27 and August 2 at an average price of $63,957, according to a regulatory filing. The company used approximately half the proceeds ($52.4M) to fund preferred-stock dividends and the remainder to repurchase STRC shares. MicroStrategy also raised $290.6M through its at-the-market offering program, allocating $250M to its US dollar reserve and $28.9M to other purposes. The BTC sale is notable because it signals Saylor's willingness to rebalance the company's treasury strategy—previously, MicroStrategy had been a net buyer of Bitcoin. The sale suggests Saylor believes the company's equity is undervalued relative to its Bitcoin holdings, making share buybacks more attractive than accumulating additional BTC at current prices. This is a subtle but important signal: even Bitcoin bulls are willing to take profits and diversify when equity valuations look compelling.
💡 At-the-market offering (ATM) — a program that allows a company to sell shares gradually into the market at prevailing prices, rather than in a single large offering. This provides flexibility and minimizes market impact.
US spot Solana ETFs (including Bitwise's BSOL and Fidelity's FSOL) recorded positive net inflows on every trading day in July 2026, totaling $5.75M in the first full week, according to data released Monday. The funds have accumulated more than $1B in cumulative net inflows since their October 2025 launch, even as SOL trades at $73.27, well below the $295 peak from January 2026. The persistent inflows despite price weakness signal strong institutional interest in Solana as a long-term infrastructure play. Morgan Stanley has also filed to launch its own Solana Trust, further legitimizing the ecosystem. The inflows are particularly significant because they suggest institutions are accumulating SOL at lower prices, betting on the network's technical superiority (sub-second confirmations, low fees) and growing developer ecosystem. However, SOL's 24.6% YTD decline reflects lingering concerns about network reliability and competition from Ethereum Layer-2 solutions.
Scientists studying octopus neurobiology discovered that the creatures' suckers contain chemoreceptors—sensory cells that detect chemical compounds—allowing octopuses to taste whatever they touch with their eight arms. This means an octopus can simultaneously explore and sample its environment with eight independent tasting appendages, a sensory capability humans lack entirely. The discovery helps explain how octopuses, despite having no centralized brain control over their arms (each arm operates semi-autonomously), can hunt prey, navigate complex environments, and make rapid decisions. This distributed sensory system is a reminder that intelligence and perception take radically different forms across species, and that our human-centric view of how brains work is just one narrow slice of nature's possibilities. For investors, the octopus story is a humbling reminder: the most innovative solutions often come from unexpected places, and the best strategies are those that distribute decision-making and sensing across multiple independent nodes rather than centralizing everything in one place.
💡 Chemoreceptors — sensory cells that detect and respond to chemical compounds. In humans, chemoreceptors are concentrated in the nose (smell) and mouth (taste); in octopuses, they're distributed across the suckers on all eight arms.